AU2012348529B2 - Isolated stereoisomeric forms of (S) 2-N (3-O-(propan 2-ol) -1-propyl-4-hydroxybenzene) -3-phenylpropylamide - Google Patents
Isolated stereoisomeric forms of (S) 2-N (3-O-(propan 2-ol) -1-propyl-4-hydroxybenzene) -3-phenylpropylamide Download PDFInfo
- Publication number
- AU2012348529B2 AU2012348529B2 AU2012348529A AU2012348529A AU2012348529B2 AU 2012348529 B2 AU2012348529 B2 AU 2012348529B2 AU 2012348529 A AU2012348529 A AU 2012348529A AU 2012348529 A AU2012348529 A AU 2012348529A AU 2012348529 B2 AU2012348529 B2 AU 2012348529B2
- Authority
- AU
- Australia
- Prior art keywords
- pain
- compound
- treatment
- pharmaceutical composition
- propan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/22—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161568219P | 2011-12-08 | 2011-12-08 | |
| US61/568,219 | 2011-12-08 | ||
| PCT/IL2012/050512 WO2013084238A1 (en) | 2011-12-08 | 2012-12-06 | Isolated stereoisomeric forms of (s) 2-n (3-o-(propan 2-ol) -1-propyl-4-hydroxybenzene) -3-phenylpropylamide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2012348529A1 AU2012348529A1 (en) | 2014-06-12 |
| AU2012348529B2 true AU2012348529B2 (en) | 2017-03-30 |
Family
ID=48573665
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2012348529A Active AU2012348529B2 (en) | 2011-12-08 | 2012-12-06 | Isolated stereoisomeric forms of (S) 2-N (3-O-(propan 2-ol) -1-propyl-4-hydroxybenzene) -3-phenylpropylamide |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9381173B2 (enExample) |
| EP (1) | EP2788317B1 (enExample) |
| JP (2) | JP6411893B2 (enExample) |
| CN (1) | CN103998420B (enExample) |
| AU (1) | AU2012348529B2 (enExample) |
| CA (1) | CA2856665C (enExample) |
| DK (1) | DK2788317T3 (enExample) |
| ES (1) | ES2763946T3 (enExample) |
| HU (1) | HUE048570T2 (enExample) |
| IN (1) | IN2014MN00919A (enExample) |
| WO (1) | WO2013084238A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015173813A1 (en) * | 2014-05-14 | 2015-11-19 | Novaremed Ltd. | Pharmaceutical composition comprising stereoisomers of n-(1-(4-hydroxyphenyl)-3-(2-hydroxypropoxy)propan-2-yl)-3-phenylpropanamide for the prevention and treatment of type ii diabetes |
| KR102062268B1 (ko) | 2018-05-18 | 2020-01-03 | 한국교통대학교 산학협력단 | 발광 특성 또는 전하 전달 특성이 우수한 아지드계 가교제 |
| JP7611148B2 (ja) * | 2019-01-23 | 2025-01-09 | ノヴァレメド リミテッド | 疼痛、炎症および／または自己免疫の処置または予防における使用のための化合物 |
| EP3939578A1 (en) | 2020-07-13 | 2022-01-19 | Novaremed Ltd. | Compounds for treatment or prevention of an infection resulting from a coronavirus and/or a coronavirus-induced disease |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110086910A1 (en) * | 2009-09-09 | 2011-04-14 | Novaremed Limited | Method of treating or preventing pain |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004031129A2 (en) | 2002-10-03 | 2004-04-15 | New Era Biotech, Ltd. | Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection |
| US7674829B2 (en) | 2004-03-26 | 2010-03-09 | Novaremed Limited | Compounds for the treatment of AIDS and other viral diseases |
| US20090197781A1 (en) | 2008-01-31 | 2009-08-06 | Hari Babu Sunkara | Wellbore Fluids Comprising Poly(trimethylene ether) glycol Polymers |
| GB0804213D0 (en) * | 2008-03-06 | 2008-04-16 | New Era Biotech Ltd | A method of printing or preventing pain |
| HUE047515T2 (hu) | 2009-09-09 | 2020-04-28 | Novaremed Ltd | N-Szubsztituált benzolpropánamidok fájdalom és gyulladás kezelésében történõ alkalmazásra |
| GB0916073D0 (en) | 2009-09-14 | 2009-10-28 | Cintec Int Ltd | Improvements in and relating to building anchor systems |
-
2012
- 2012-12-06 CA CA2856665A patent/CA2856665C/en active Active
- 2012-12-06 HU HUE12855522A patent/HUE048570T2/hu unknown
- 2012-12-06 WO PCT/IL2012/050512 patent/WO2013084238A1/en not_active Ceased
- 2012-12-06 CN CN201280060570.9A patent/CN103998420B/zh active Active
- 2012-12-06 AU AU2012348529A patent/AU2012348529B2/en active Active
- 2012-12-06 ES ES12855522T patent/ES2763946T3/es active Active
- 2012-12-06 JP JP2014545450A patent/JP6411893B2/ja active Active
- 2012-12-06 EP EP12855522.4A patent/EP2788317B1/en active Active
- 2012-12-06 DK DK12855522.4T patent/DK2788317T3/da active
-
2014
- 2014-05-16 IN IN919MUN2014 patent/IN2014MN00919A/en unknown
- 2014-05-30 US US14/291,901 patent/US9381173B2/en active Active
-
2017
- 2017-07-21 JP JP2017142137A patent/JP2018021023A/ja active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110086910A1 (en) * | 2009-09-09 | 2011-04-14 | Novaremed Limited | Method of treating or preventing pain |
Also Published As
| Publication number | Publication date |
|---|---|
| HK1201059A1 (en) | 2015-08-21 |
| WO2013084238A1 (en) | 2013-06-13 |
| US20140275270A1 (en) | 2014-09-18 |
| EP2788317A4 (en) | 2015-07-08 |
| JP6411893B2 (ja) | 2018-10-31 |
| EP2788317B1 (en) | 2019-10-02 |
| CA2856665A1 (en) | 2013-06-13 |
| IN2014MN00919A (enExample) | 2015-04-17 |
| HUE048570T2 (hu) | 2020-08-28 |
| US9381173B2 (en) | 2016-07-05 |
| CA2856665C (en) | 2019-11-12 |
| JP2015500831A (ja) | 2015-01-08 |
| AU2012348529A1 (en) | 2014-06-12 |
| DK2788317T3 (da) | 2020-01-20 |
| CN103998420B (zh) | 2018-04-17 |
| EP2788317A1 (en) | 2014-10-15 |
| JP2018021023A (ja) | 2018-02-08 |
| CN103998420A (zh) | 2014-08-20 |
| ES2763946T3 (es) | 2020-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0934061B1 (en) | Isobutylgaba and its derivatives for the treatment of pain | |
| Leggio et al. | Effectiveness and safety of baclofen in the treatment of alcohol dependent patients | |
| Walker | Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, 1994: NSAID: An Update on Their Analgesic Effects | |
| US9381173B2 (en) | Isolated stereoisomeric forms of (S)2-N(3-O-(propan 2-Ol)-1-propyl-4-hydroxybenzene)-3-phenylpropylamide | |
| US10265304B2 (en) | Nootropic compositions for improving memory performance | |
| Zorowitz et al. | Usage of pain medications during stroke rehabilitation: the Post-Stroke Rehabilitation Outcomes Project (PSROP) | |
| EP1219624B1 (en) | Remedies for neuropathic pain and model animals of neuropathic pain | |
| Huang et al. | Sinomenine-induced histamine release-like anaphylactoid reactions are blocked by tranilast via inhibiting NF-κB signaling | |
| US6774131B1 (en) | Remedies for endothelin-induced diseases | |
| Norkus et al. | Pharmacokinetics of intravenous and oral amitriptyline and its active metabolite nortriptyline in Greyhound dogs | |
| Kotagale et al. | Agmatine prevents development of tolerance to anti-nociceptive effect of ethanol in mice | |
| Negus et al. | Effects of chronic methadone treatment on cocaine-and food-maintained responding under second-order, progressive-ratio and concurrent-choice schedules in rhesus monkeys | |
| AU2005223655B2 (en) | Methods for treating alcoholism | |
| RU2322977C1 (ru) | Синтетическое анальгетическое средство и способ лечения на основе этого средства | |
| HK1201059B (en) | Isolated stereoisomeric forms of (s) 2-n (3-o-(propan 2-ol) -1-propyl-4-hydroxybenzene) -3-phenylpropylamide | |
| JP6461961B2 (ja) | ジエチル（２−シアノエチル）ホスホネートの医薬組成物および使用 | |
| CN1196932A (zh) | (+)－o－去甲基反胺苯环醇作为止痛药的口服应用 | |
| EP2545915A1 (en) | 2-amino-2-oxoethyl trans-3-[5-(6-methoxy-naphtalen-1-yl)-1,3-dioxan-2-yl]propyl-carbamate for use in the treatment of persistent cancer pain | |
| BRPI0613281A2 (pt) | combinação terapêutica contendo um bloqueador de receptor nmda e uma substáncia analgésica e narcótica | |
| EP2545914A1 (en) | 2-amino-2-oxoethyl trans-3-[5-(6-methoxy-naphtalen-1-yl)-1,3-dioxan-2-yl]propyl-carbamate for use in the treatment of persistent cancer pain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) |